Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News TCT 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

Todd Neale

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2020

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

News Conference News TCT 2015

VISION: OCT-Guided Atherectomy Safe, Effective for PAD Intervention

October 14, 2015

Presentation TCT 2014

NIRS for Identifying Vulnerable Plaque Prior to Coronary Thrombosis

Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, Akiko Maehara

September 13, 2014

Presentation TCT 2014

TCT 313: Characterization of Lesion Shape and Hemodynamic Forces Acting on Coronary Artery Atherosclerotic Plaques Using Computational Flow Dynamics and Computed Tomography Data

Presenter: Valentin Fuster, Bon-Kwon Koo

September 13, 2014

Presentation TCT 2013

Neoatherosclerosis: OCT and NIRS Findings and Their Clinical Implications

Presenter: Ziad Ali

October 31, 2013

Presentation TCT 2013

Neoatherosclerosis: Clinical Implications (with Case Vignettes)

Presenter: Giora Weisz

October 30, 2013

Presentation TCT 2013

Are Calcific Nodules Vulnerable? Pathologic and Clinical Perspectives

Presenter: Gary Mintz

October 30, 2013

Presentation TCT 2012

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

Should VH-IVUS Be Used as a Clinical Tool to Detect and Treat Vulnerable Plaque TODAY: From PROSPECT to VIVA

Presenter: Patrick Calvert

October 23, 2012

Presentation TCT 2012

OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies

Presenter: Shiro Uemura

October 23, 2012

Presentation TCT 2012

NIRS as a Clinical Tool for Vulnerable Plaque Detection: Findings in Patients with Acute STEMI

Presenter: Ryan Madder

October 23, 2012

Presentation TCT 2012

Neoatherosclerosis Mediated Plaque Vulnerability and Periprocedural Myocardial Infarction

Presenter: Ziad Ali

October 22, 2012

Presentation TCT 2012

Neoatherosclerosis After BMS and DES: Pathologic Insights

Presenter: Renu Virmani

October 22, 2012

Presentation TCT 2012

Neoatherosclerosis After BMS and DES: Experimental Insights

Presenter: Greg Kaluza

October 22, 2012

Presentation TCT 2012

Imaging Studies of Late Restenosis and/or Stent Thrombosis: Is Neoatherosclerosis the Final Common Pathway of DES Failure?

Presenter: Soo-Jin Kang

October 22, 2012

Advertisement

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

What’s Going to Be Hot at TCT 2025

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

VISION: OCT-Guided Atherectomy Safe, Effective for PAD Intervention

NIRS for Identifying Vulnerable Plaque Prior to Coronary Thrombosis

TCT 313: Characterization of Lesion Shape and Hemodynamic Forces Acting on Coronary Artery Atherosclerotic Plaques Using Computational Flow Dynamics and Computed Tomography Data

Neoatherosclerosis: OCT and NIRS Findings and Their Clinical Implications

Neoatherosclerosis: Clinical Implications (with Case Vignettes)

Are Calcific Nodules Vulnerable? Pathologic and Clinical Perspectives

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

Should VH-IVUS Be Used as a Clinical Tool to Detect and Treat Vulnerable Plaque TODAY: From PROSPECT to VIVA

OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies

NIRS as a Clinical Tool for Vulnerable Plaque Detection: Findings in Patients with Acute STEMI

Neoatherosclerosis Mediated Plaque Vulnerability and Periprocedural Myocardial Infarction

Neoatherosclerosis After BMS and DES: Pathologic Insights

Neoatherosclerosis After BMS and DES: Experimental Insights

Imaging Studies of Late Restenosis and/or Stent Thrombosis: Is Neoatherosclerosis the Final Common Pathway of DES Failure?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content